1,25 dihydroxyvitamin D3 limits monocyte maturation in lupus sera

Lupus

Volumn 20, Issue 7, 2011, Pages 749-753

  Lerman, M A ^a,b   Burnham, J M ^a,b   Behrens, E M ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

antigen presenting cells; monocytes; systemic lupus erythematosus; vitamin D

Indexed keywords

ALPHA INTERFERON; CALCITRIOL; CD14 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CELL SURFACE MARKER; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOMODULATION; IN VITRO STUDY; MALE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ANTIGEN-PRESENTING CELLS; CALCITRIOL; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CYTOKINES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MONOCYTES; PHENOTYPE; VITAMINS; YOUNG ADULT;

EID: 79957598676     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203310394542     Document Type: Article

References (15)

1. Santini SM, Lapenta C, Logozzi M, et al. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in hu-pbl-scid mice. J Exp Med. 2000 ; 19: 1777-1788 (Pubitemid 30331574)
2. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994 ; 179: 1109-1118
3. Baechler EC, Batliwalla FM, Karypis G, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A. 2003 ; 100: 2610-2615 (Pubitemid 36297546)
4. Bennett L, Palucka AK, Arce E, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med. 2003 ; 17; 197: 711-723 (Pubitemid 36350866)
5. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by ifn-alpha in systemic lupus erythematosus. Science. 2001 ; 294: 1540-1543 (Pubitemid 33063928)
6. Penna G, Adorini L. 1 alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol. 2000 ; 164: 2405-2411 (Pubitemid 30115468)
7. Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1±, 25-dihydroxyvitamin D3 analog enhances regulatory t-cells and arrests autoimmune diabetes in NOD mice. Diabetes. 2002 ; 51: 1367-1374 (Pubitemid 34826601)
8. Gauzzi MC, Purificato C, Donato K, et al. Suppressive effect of 1 alpha, 25-dihydroxyvitamin D3 on type I ifn-mediated monocyte differentiation into dendritic cells: Impairment of functional activities and chemotaxis. J Immunol. 2005 ; 174: 270-276 (Pubitemid 40007413)
9. Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R. Dendritic cell modulation by 1±, 25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U S A. 2001 ; 98: 6800-6805 (Pubitemid 32538297)
10. Széles L, Keresztes G, Töröcsik D, et al. 1,25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype. J Immunol. 2009 ; 182: 2074-2083
11. Amital H, Szekanecz Z, Szücs G, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: Is it time to routinely supplement patients with SLE with vitamin D?. Ann Rheum Dis. 2010 ; 69: 1155-1157
12. Wright TB, Shults J, Leonard MB, Zemel BS, Burnham JM. Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. J Pediatr. 2009 ; 155: 260-265
13. Hochberg MC. For the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum. 1997 ; 40: 1725-1725
14. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992 ; 35: 630-640
15. Adorini L, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol. 2008 ; 4: 404-412